A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

GLYC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.70%

Insider Buying (Last 12 Months): $116,295.00

Insider Selling (Last 12 Months): $7,215.00

GlycoMimetics Insider Trading History Chart

GlycoMimetics Share Price & Price History

^$1.93

▼ -0.24 (-11.09%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Secret Bull Market Starts in This Unusual Sector

From Altimetry | Ad

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

GlycoMimetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/21/2023	Edwin Rock	Insider	Buy	35,000	$1.38	$48,300.00	345,000
5/17/2023	Brian M Hahn	CFO	Sell	3,700	$1.95	$7,215.00	53,143
5/10/2023	Daniel M Junius	Director	Buy	30,000	$1.56	$46,800.00	93,250
5/8/2023	Bruce S Johnson	SVP	Buy	13,500	$1.57	$21,195.00	138,980
2/23/2023	Public Equities L.P. Invus	Major Shareholder	Buy	200,000	$1.75	$350,000.00	8,489,064
2/21/2023	Public Equities L.P. Invus	Major Shareholder	Buy	50,000	$1.85	$92,500.00	8,139,064
2/17/2023	Public Equities L.P. Invus	Major Shareholder	Buy	200,000	$1.71	$342,000.00	8,089,064
2/15/2023	Public Equities L.P. Invus	Major Shareholder	Buy	1,000,000	$2.16	$2,160,000.00	7,573,798
2/9/2023	Public Equities L.P. Invus	Major Shareholder	Buy	11,451	$3.24	$37,101.24	6,573,798
1/25/2023	Scott D Sandell	Major Shareholder	Sell	652,016	$3.26	$2,125,572.16	3,588,288
1/5/2023	Scott D Sandell	Major Shareholder	Sell	71,362	$2.76	$196,959.12	3,881,933
1/3/2023	Scott D Sandell	Major Shareholder	Sell	174,814	$2.99	$522,693.86	3,960,002
12/22/2022	Edwin Rock	Insider	Buy	110,000	$2.25	$247,500.00	310,000
11/14/2022	Edwin Rock	Insider	Buy	100,000	$1.43	$143,000.00	100,000
3/9/2022	Brian M Hahn	CFO	Sell	2,917	$1.09	$3,179.53
3/9/2022	John L Magnani	SVP	Sell	3,227	$1.09	$3,517.43
11/16/2021	Patricia S. Andrews	Director	Buy	40,000	$2.05	$82,000.00

Secret Bull Market Starts in This Unusual Sector

From Altimetry | Ad

Click for my No. 1 investment, all free of charge, click here.

SEC Filings (Institutional Ownership Changes) for GlycoMimetics (NASDAQ:GLYC)

75.19% of GlycoMimetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GlycoMimetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/1/2024	Goldman Sachs Group Inc.	919,355	$2.17M	0.0%	+15.7%	1.428%
2/26/2024	Virtu Financial LLC	34,319	$81K	0.0%	N/A	0.053%
2/16/2024	GSA Capital Partners LLP	200,993	$0.47M	0.0%	+114.3%	0.312%
2/15/2024	Bridgeway Capital Management LLC	197,200	$0.47M	0.0%	+14.5%	0.306%
2/13/2024	Northern Trust Corp	111,254	$0.26M	0.0%	+4.7%	0.173%
2/13/2024	Goldman Sachs Group Inc.	919,355	$2.17M	0.0%	+15.7%	1.428%
2/8/2024	Advisor OS LLC	101,000	$0.24M	0.0%	N/A	0.157%
2/5/2024	Intellectus Partners LLC	50,720	$0.12M	0.0%	-18.2%	0.079%
1/18/2024	MJP Associates Inc. ADV	101,000	$0.24M	0.1%	N/A	0.157%
12/18/2023	Vanguard Group Inc.	2,421,869	$3.63M	0.0%	+4.6%	3.761%
11/15/2023	GSA Capital Partners LLP	93,785	$0.14M	0.0%	N/A	0.146%
11/15/2023	Acuta Capital Partners LLC	27,500	$41K	0.0%	N/A	0.043%
11/13/2023	Acadian Asset Management LLC	844,051	$1.27M	0.0%	-26.6%	1.311%
11/13/2023	Sargent Investment Group LLC	58,000	$87K	0.0%	-46.3%	0.090%
10/25/2023	Intellectus Partners LLC	61,975	$93K	0.0%	-15.7%	0.096%
8/15/2023	XTX Topco Ltd	29,998	$52K	0.0%	N/A	0.047%
8/15/2023	Goldman Sachs Group Inc.	783,731	$1.36M	0.0%	-13.1%	1.218%
8/14/2023	Marshall Wace LLP	142,400	$0.25M	0.0%	-34.2%	0.221%
8/11/2023	Renaissance Technologies LLC	116,100	$0.20M	0.0%	-18.9%	0.181%
8/11/2023	BlackRock Inc.	783,905	$1.36M	0.0%	+20.8%	1.219%
8/11/2023	Geode Capital Management LLC	476,240	$0.83M	0.0%	+17.5%	0.740%
8/11/2023	Northern Trust Corp	120,873	$0.21M	0.0%	+17.7%	0.188%
8/7/2023	Acadian Asset Management LLC	1,149,656	$2M	0.0%	-18.0%	1.788%
7/31/2023	Intellectus Partners LLC	73,475	$0.13M	0.0%	-10.1%	0.114%
7/18/2023	Stratos Wealth Partners LTD.	33,340	$58K	0.0%	-67.5%	0.052%
5/16/2023	State Street Corp	186,765	$0.24M	0.0%	+19.3%	0.291%
5/15/2023	Two Sigma Advisers LP	594,500	$0.75M	0.0%	+210.0%	0.925%
5/15/2023	Two Sigma Investments LP	370,569	$0.47M	0.0%	+69.7%	0.577%
5/15/2023	AXA S.A.	1,609,061	$2.03M	0.0%	N/A	2.505%
5/12/2023	Renaissance Technologies LLC	143,100	$0.18M	0.0%	-44.3%	0.223%
5/12/2023	BlackRock Inc.	648,915	$0.82M	0.0%	-14.5%	1.010%
5/12/2023	Dimensional Fund Advisors LP	66,785	$84K	0.0%	-10.1%	0.104%
5/11/2023	Letko Brosseau & Associates Inc.	45,250	$57K	0.0%	N/A	0.070%
5/11/2023	Acadian Asset Management LLC	1,401,653	$1.77M	0.0%	-27.9%	2.182%
5/10/2023	Beirne Wealth Consulting Services LLC	50,000	$63K	0.0%	+25.0%	0.078%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	159,001	$0.20M	0.0%	+143.5%	0.247%
5/9/2023	Tower Research Capital LLC TRC	24,441	$30K	0.0%	N/A	0.038%
5/5/2023	Truist Financial Corp	101,000	$0.13M	0.0%	N/A	0.157%
5/2/2023	Sargent Investment Group LLC	108,000	$0.14M	0.0%	N/A	0.168%
4/27/2023	Stratos Wealth Partners LTD.	102,565	$0.13M	0.0%	N/A	0.160%
4/26/2023	Chicago Partners Investment Group LLC	20,000	$28K	0.0%	N/A	0.031%
2/15/2023	Jane Street Group LLC	24,800	$75K	0.0%	N/A	0.047%
2/15/2023	Morgan Stanley	16,342	$50K	0.0%	-62.5%	0.031%
2/15/2023	First Manhattan Co.	314,141	$0.95M	0.0%	N/A	0.599%
2/15/2023	Freedom Wealth Alliance LLC	9,452	$29K	0.0%	N/A	0.018%
2/14/2023	Marshall Wace LLP	208,941	$0.63M	0.0%	N/A	0.399%
2/14/2023	Two Sigma Investments LP	218,363	$0.66M	0.0%	-4.4%	0.417%
2/13/2023	Charles Schwab Investment Management Inc.	22,361	$68K	0.0%	N/A	0.043%
2/13/2023	Renaissance Technologies LLC	257,000	$0.78M	0.0%	-51.2%	0.490%
2/13/2023	Geode Capital Management LLC	405,335	$1.23M	0.0%	+13.1%	0.773%
2/10/2023	NEA Management Company LLC	8,967,706	$27.17M	1.5%	-1.3%	17.107%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	65,288	$0.20M	0.0%	N/A	0.125%
2/9/2023	Dimensional Fund Advisors LP	74,278	$0.23M	0.0%	N/A	0.142%
2/8/2023	Beirne Wealth Consulting Services LLC	40,000	$0.12M	0.1%	N/A	0.076%
2/2/2023	Intellectus Partners LLC	81,730	$0.25M	0.1%	-32.2%	0.156%
1/31/2023	AE Wealth Management LLC	26,898	$82K	0.0%	N/A	0.051%
11/15/2022	Two Sigma Advisers LP	206,900	$0.11M	0.0%	-34.8%	0.395%
11/15/2022	Two Sigma Investments LP	228,303	$0.13M	0.0%	-29.2%	0.435%
11/15/2022	Vanguard Group Inc.	1,879,412	$1.04M	0.0%	+1.8%	3.585%
11/14/2022	Renaissance Technologies LLC	526,300	$0.29M	0.0%	-7.1%	1.004%
8/15/2022	Millennium Management LLC	434,655	$0.26M	0.0%	+7.5%	0.829%
8/13/2022	Renaissance Technologies LLC	566,400	$0.34M	0.0%	+20.4%	1.080%
8/12/2022	Franklin Resources Inc.	119,329	$71K	0.0%	-26.0%	0.228%
5/13/2022	Renaissance Technologies LLC	470,600	$0.54M	0.0%	-21.7%	0.898%
5/13/2022	Federated Hermes Inc.	217,116	$0.25M	0.0%	-37.2%	0.414%
5/13/2022	Vanguard Group Inc.	1,814,963	$2.07M	0.0%	-18.9%	3.464%
5/13/2022	Dimensional Fund Advisors LP	271,129	$0.31M	0.0%	-52.0%	0.518%
5/12/2022	Acadian Asset Management LLC	1,990,087	$2.27M	0.0%	+2.0%	3.798%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	89,926	$0.10M	0.0%	-24.7%	0.172%
2/14/2022	Eversept Partners LP	100,000	$0.14M	0.0%	N/A	0.193%
2/14/2022	GSA Capital Partners LLP	146,078	$0.21M	0.0%	N/A	0.282%
2/10/2022	Acadian Asset Management LLC	1,951,086	$2.81M	0.0%	+3.4%	3.771%
11/16/2021	Two Sigma Advisers LP	621,000	$1.36M	0.0%	-12.4%	1.200%
11/16/2021	Two Sigma Investments LP	498,530	$1.09M	0.0%	+121.0%	0.964%
11/15/2021	Dimensional Fund Advisors LP	904,628	$1.98M	0.0%	-23.3%	1.748%
11/15/2021	Franklin Resources Inc.	160,700	$0.35M	0.0%	N/A	0.311%
11/12/2021	Renaissance Technologies LLC	596,100	$1.31M	0.0%	-21.3%	1.152%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	112,298	$0.25M	0.0%	+5.5%	0.217%
11/9/2021	BlackRock Inc.	875,151	$1.92M	0.0%	-1.2%	1.691%
8/17/2021	Millennium Management LLC	686,577	$1.59M	0.0%	+1,284.5%	1.332%
8/17/2021	Bridgeway Capital Management LLC	215,700	$0.50M	0.0%	+26.4%	0.419%
8/16/2021	Squarepoint Ops LLC	16,216	$38K	0.0%	N/A	0.031%
8/16/2021	AQR Capital Management LLC	97,590	$0.23M	0.0%	-54.0%	0.189%
8/16/2021	LMR Partners LLP	22,889	$53K	0.0%	N/A	0.044%
8/16/2021	Charles Schwab Investment Management Inc.	11,422	$27K	0.0%	-87.0%	0.022%
8/16/2021	State Street Corp	144,265	$0.34M	0.0%	-77.9%	0.280%
8/16/2021	Tibra Equities Europe Ltd	136,100	$0.32M	0.1%	N/A	0.264%
8/16/2021	Goldman Sachs Group Inc.	123,407	$0.29M	0.0%	+253.3%	0.239%
8/13/2021	Renaissance Technologies LLC	757,693	$1.76M	0.0%	+20.9%	1.470%
8/13/2021	Northern Trust Corp	108,713	$0.25M	0.0%	-71.8%	0.211%
8/13/2021	Intellectus Partners LLC	123,000	$0.29M	0.1%	+51.9%	0.239%
8/13/2021	Jump Financial LLC	18,000	$42K	0.0%	N/A	0.035%
8/13/2021	QS Investors LLC	160,700	$0.37M	0.0%	+58.3%	0.312%
8/13/2021	Qube Research & Technologies Ltd	14,488	$34K	0.0%	N/A	0.028%
8/13/2021	Geode Capital Management LLC	352,740	$0.82M	0.0%	-51.0%	0.684%
8/13/2021	Vanguard Group Inc.	2,270,457	$5.27M	0.0%	-14.6%	4.405%
8/12/2021	XTX Topco Ltd	58,992	$0.14M	0.0%	N/A	0.114%
8/12/2021	Dimensional Fund Advisors LP	1,178,938	$2.74M	0.0%	-2.9%	2.287%
8/12/2021	Advisory Services Network LLC	35,800	$83K	0.0%	N/A	0.069%
8/12/2021	JPMorgan Chase & Co.	263,914	$0.61M	0.0%	+4.6%	0.512%

Data available starting January 2016

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and inflammatory diseases with unmet needs in the United States. It is developing uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat AML, as well as in phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and galectin-3 antagonists, a carbohydrate-binding protein. In addition, it is developing GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of cancers that affect the bone and bone marrow, including solid tumors. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

Today's Range

Now: $1.93

$1.88

$2.17

50 Day Range

MA: $2.83

$2.15

$3.33

52 Week Range

Now: $1.93

$1.11

$3.53

Volume

1,168,469 shs

Average Volume

418,434 shs

Market Capitalization

$124.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18

Who are the company insiders with the largest holdings of GlycoMimetics?: GlycoMimetics' top insider shareholders include:
Public Equities LP Invus (Major Shareholder)
Scott D Sandell (Major Shareholder)
Edwin Rock (Insider)
Bruce S Johnson (SVP)
Daniel M Junius (Director)
Brian M Hahn (CFO)
Learn More about top insider investors at GlycoMimetics.

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad